Enterprise Value
26.67M
Cash
7.179M
Avg Qtr Burn
-1.90M
Short % of Float
0.25%
Insider Ownership
21.10%
Institutional Own.
12.08%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ibezapolstat Details Clostridioides difficile infection | Phase 2b Interim update |